Viswanath Das

11PUBLICATIONS
17CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsMedical infection agents (incl. prions)Neurology and neuromuscular diseasesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 12, 2026
Oncology drug repurposing as a blueprint for Alzheimer's therapy.

Viswanath Das, Marián Hajdúch

|Dec 08, 2025
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors.

Sudhakar Tangallapalli, Rambabu Gundla, Kalyani Paidikondala

|Aug 27, 2025
Structural and functional insights into the selective inhibition of mutant tau aggregation by purpurin and oleocanthal in frontotemporal dementia.

Alladi Charanraj Goud, Ihor Kozlov, Patricie Skoupilová

|Aug 17, 2025
Hydrophobic residues in the α-synuclein NAC domain drive seed-competent fibril formation and are targeted by peptide inhibitors.

Viswanath Das, Sayed Mostafa Modarres Mousavi, Narendran Annadurai

|Mar 26, 2024
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies.

Viswanath Das, John H Miller, Charanraj Goud Alladi

|Feb 26, 2024
Novel 5-Substituted Oxindole Derivatives as Bruton's Tyrosine Kinase Inhibitors: Design, Synthesis, Docking, Molecular Dynamics Simulation, and Biological Evaluation.

Vani Madhuri Velavalapalli, Venkatanarayana Chowdary Maddipati, Soňa Gurská

Pageof 2

Frequent Collaborators

2 joint publications

Bohumír Grüner

2 joint publications

Jan Nekvinda

2 joint publications

Marián Hajdúch

2 joint publications

Naresh Kumar Katari